# Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS

> **NCT00152373** · PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 192 (—)

## Conditions studied

- Epilepsy, Partial

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT00152373
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 192 (—)
- **Last updated:** 2013-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152373, "Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT00152373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*